Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals - Chief Executive Officer and President Keisha Harcum - Vice President, Finance Conference Call Participants Nick Sherwood - Maxim Group. Bruce Jackson - Benchmark Company Operator Good morning, everyone.
- 11/15/2024
|
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
- Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended September 30, 2024.
- 11/14/2024
|
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
- ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition.
- 11/14/2024
|
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
- ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company's financial results for the third quarter ended September 30, 2024, as well as the company's corporate progress and other developments.
- 11/12/2024
|
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
- Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz.
- 11/01/2024
|
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment
- Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership with Axial Biologics Reports Robust Pipeline of Clinics in Trials Across Multiple States through Partnership with Axial Biologics
- 10/03/2024
|
Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants David Waldman - Investor Relations, Crescendo Communications Arjan Haverhals - Chief Executive Officer Keisha Harcum - Vice President, Finance Conference Call Participants Anthony Vendetti - The Maxim Group Operator Good morning, and welcome to the Milestone Scientific Second Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode and we will open for questions following the presentation.
- 08/15/2024
|
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
- Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driven by an increase in U.S. e-commerce sales ROSELAND, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the second quarter ended June 30, 2024.
- 08/15/2024
|
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
- ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, August 15th, 2024, to discuss the company's financial results for the second quarter ended June 30, 2024, as well as the company's corporate progress and other developments.
- 08/12/2024
|
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
- ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a strategic partnership with Axial Biologics, a premier medical device company with a vast distribution network. Under the agreement, Axial Biologics will serve as the distributor of Milestone Scientific's CompuFlo® Epidural System in New Jersey, Texas, and Florida.
- 08/07/2024
|
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
- ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced receipt of multiple Notices of Allowance (NOA) for essential patent applications in both the U.S. and Europe.
- 07/30/2024
|
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
- ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Novitas Solutions, Inc. (Novitas), a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the Company's CompuFlo® Epidural System under the American Medical Association's (AMA) technology-specific Category III CPT® code CPT0777T (real-time pressure-sensing epidural guidance system when used in conjunction with a primary ESI procedure).
- 07/23/2024
|
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
- Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain
- 06/18/2024
|
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
- 05/16/2024
|
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
- Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended March 31, 2024.
- 05/16/2024
|
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
- ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company's financial results for the first quarter ended March 31, 2024, as well as the company's corporate progress and other developments.
- 05/13/2024
|
Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript
- 04/01/2024
|
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
- Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technology Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technology
- 04/01/2024
|
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
- ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company's financial results for 2023, as well as the company's corporate progress and other developments
- 03/28/2024
|
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
- Follows successful evaluation by Omaha Pain Physicians' founder and medical director, Dr. Matthew Stottle, reporting 100% success Follows successful evaluation by Omaha Pain Physicians' founder and medical director, Dr. Matthew Stottle, reporting 100% success
- 03/14/2024
|
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
- ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio, a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.
- 02/28/2024
|
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
- ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group, a premier group of 21 dental practices across the northeastern United States.
- 02/20/2024
|
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
- Reports initial reimbursements of CompuFlo® by commercial payors and Medicare Reports initial reimbursements of CompuFlo® by commercial payors and Medicare
- 01/16/2024
|
PRISM Emerging MedDevices Mover Spotlight: Milestone Scientific Inc. (MLSS)
- New York, December 27, 2023 – Milestone Scientific Inc. (NYSE:MLSS) has established itself in the field of biomedical technology with its focus on advanced injection technologies for medical and dental applications. The company holds over 19 US patents and 133 foreign patents.
- 12/27/2023
|
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
- ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”). Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately $3.0 million.
- 12/13/2023
|
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
- ROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share (the “Offering”). Gross proceeds before underwriting discounts and commissions and estimated Offering expenses are expected to be approximately $3.0 million. The Offering is expected to close on December 13, 2023, subject to customary closing conditions.
- 12/10/2023
|
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
- ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock (the “Offering”). The Company also expects to grant to the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the Offering on the same terms and conditions. All of the shares of common stock are being offered by the Company. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
- 12/08/2023
|
Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures
- Adoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success
- 12/08/2023
|
Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain
- ROSELAND, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain. Bioline is a premier distributor of medical devices and equipment, supporting many hospitals and pain clinics across Spain. In connection with the agreement, Milestone Scientific has commenced sales and shipments of its CompuFlo Epidural Instrument and consumables to Spain.
- 11/28/2023
|
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023
- Reports 45% increase in domestic sales for the third quarter of 2023; new online store providing greater interaction with dentists and improved margins
- 11/15/2023
|
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
- ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company's financial results for the third quarter ended September 30, 2023, as well as the company's corporate progress and other developments.
- 11/10/2023
|
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York
- Represents first sales by the Company into an ambulatory surgery center Follows successful evaluation by Island Ambulatory Surgery Center's founder and medical director, Dr. Leon Reyfman, reporting 100% success ROSELAND, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into Island Ambulatory Surgery Center, a multi-specialty ambulatory surgery center based in Brooklyn, New York with a focus on pain management, orthopedics and spine care, urology, podiatry and plastic surgery.
- 11/09/2023
|
Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
- ROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors.
- 09/12/2023
|
Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tucker Andersen - Above All Advisors Operator Greetings, and welcome to the Milestone Scientific Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
- 08/15/2023
|
Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023
- Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and improved margins Medical division reports positive reimbursement from first commercial payers ROSELAND, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2023.
- 08/15/2023
|
Milestone Scientific: Buy For The $4 Billion Total Addressable Market
- Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer local anesthesia called SingleTooth Anesthesia. The company meets key investment criteria such as a large total addressable market, low institutional ownership, and high Quant ratings. Despite the high level of risk associated with micro caps, I recommend building a small position in the stock for risk-tolerant investors due to its significant upside potential.
- 06/15/2023
|
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
- ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that Arjan Haverhals, CEO of Milestone Scientific will be presenting at the Maxim Group Virtual Healthcare Conference, hosted by M-Vest, which is being held June 20-22, 2023.
- 06/15/2023
|
Milestone Scientific: Sales Could Start To Snowball
- The shift to online sales in their dental business produced unexpectedly fast results with revenue and gross margin up sharply and more to come. Most if not all of the pieces necessary for CompuFlo sales to take off are now in place, sales could start to snowball this year. In years to come, CompuFlo could even become the standard of care.
- 06/10/2023
|
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
- ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11, 2023, to discuss the company's financial results for the first quarter ended March 31, 2023, as well as the company's corporate progress and other developments.
- 05/05/2023
|
Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer of Milestone Scientifi Conference Call Participants Anthony Vendetti - Maxim Group Mike Pfeffer - Oppenheimer Operator Greetings. Welcome to the Milestone Scientific 2022 Year-end Financial Results and Business Update Conference Call.
- 03/31/2023
|
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
- ROSELAND, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, March 31, 2023, to discuss the company's financial results for 2022, as well as the company's corporate progress and other developments.
- 03/29/2023
|
Milestone Scientific Inc. (MLSS) Q3 2022 Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day ladies and gentlemen and welcome to the Milestone Scientific's Third Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.
- 11/15/2022
|
Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th
- ROSELAND, NJ / ACCESSWIRE / October 6, 2022 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois. Mr. Haverhals is scheduled to present on Wednesday, October 12th at 2:30 p.m.
- 10/06/2022
|
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q2 2022 Results - Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen. Thank you for standing by.
- 08/16/2022
|
Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call
- ROSELAND, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 16, 2022, to discuss the company's financial results for the second quarter ended June 30, 2022, as well as the company's corporate progress and other developments.
- 08/12/2022
|
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q1 2022 Results - Earnings Call Transcript
- Milestone Scientific Inc. (NYSE:MLSS ) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific First Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode, and the floor will be opened for questions and comments after the presentation.
- 05/17/2022
|
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
- ROSELAND, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17, 2022, to discuss the company's financial results for the first quarter ended March 31, 2022, as well as the company's corporate progress and other developments.
- 05/13/2022
|
Milestone Scientific Is Attractive Here
- A new focus on their Dental business and the easing of the pandemic produced a strong recovery which has legs. The growth of the installed base of devices produces a large tail of high-margin consumables in Dental, but this will ensue with the CompuFlow as well when the base grows.
- 04/19/2022
|
Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
- ROSELAND, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at the Noble Capital Markets Eighteenth Annual Investor Conference being held on April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida.
- 04/14/2022
|
Milestone Scientific begins sales of its CompuFlo Epidural and CathCheck Verification System disposables to premier US hospital
- Milestone Scientific Inc (NYSE:MLSS), the medtech group, revealed that it has begun selling its CompuFlo Epidural and CathCheck Verification System disposables to a leading northeast medical center following a successful trial by the latter. "We are honored to announce adoption of our CompuFlo Epidural and CathCheck Verification System by another leading medical center," said Arjan Haverhals, the CEO of Milestone Scientific.
- 04/11/2022
|
Here's Why Maxim Reduced Price Target On Milestone Scientific
- Maxim has lowered the price target on Milestone Scientific Inc (NYSE: MLSS) to $4 from $6 but maintained a Buy rating on the shares. Analyst Anthony Vendetti reduced the price target due to a higher risk premium on micro-cap stocks.
- 04/04/2022
|
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q4 2021 Results - Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q4 2021 Results - Earnings Call Transcript
- 04/01/2022
|
Milestone Scientific sees its FY2021 revenue surge 90% to $10.3M as dental sales boost results
- Milestone Scientific Inc (NYSE:MLSS) has announced that its fiscal 2021 revenue climbed by 90% year over year to $10.3 million, boosted by a $4.7 million increase in its dental revenue due to the re-opening of dental offices throughout the country and the rest of the world, including China. The company said the results have surpassed its previous revenue guidance and have exceeded pre-pandemic levels.
- 04/01/2022
|
Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call
- ROSELAND, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company's financial results for the 2021 fiscal year ended December 31, 2021, as well as the company's corporate progress and other developments.
- 03/29/2022
|
Milestone Scientific Inc commences sales of CompuFlo Epidural disposables at two surgery centers in California
- Milestone Scientific Inc (NYSE:MLSS) said that it has commenced sales of the CompuFlo Epidural disposables at the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center in San Luis Obispo. Both of these prominent pain management practices are located in California and owned by Pain Management Specialists (PMS), a group of specially trained physicians, dedicated to the evaluation and treatment of acute and chronic pain.
- 03/29/2022
|
Milestone Scientific to Present at MicroCap Rodeo's Winter Wonderland Best Ideas Conference on Wednesday, February 9
- ROSELAND, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at The MicroCap Rodeo's 2nd Annual Winter Wonderland Best Ideas Conference, which is being held virtually on February 8 - 11, 2022.
- 02/07/2022
|
Milestone Scientific projects 85% rise in 2021 revenue to more than $10M as divisions gain traction
- Milestone Scientific Inc (NYSE:MLSS). has prepared investors for an 85% increase in revenue for its 2021 financial year as its dental and medical divisions continue to gain traction.
- 01/10/2022
|
Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference
- ROSELAND, N.J., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022.
- 01/07/2022
|
Milestone Scientific commences sales of its CompuFlo Epidural disposables with prominent pain clinic in North Carolina
- Milestone Scientific Inc. announced that it has commenced sales of its CompuFlo Epidural disposables with a prominent pain clinic in North Carolina. In a statement, the company said leading physician Dr. Harsh Govil, whose practice is based in Statesville, has begun incorporating the CompuFlo Epidural instrument into his practice for pain management following a successful evaluation.
- 01/06/2022
|
Milestone Scientific announces purchase of its CompuFlo Epidural and CathCheck Verification System disposables at two leading hospitals
- Milestone Scientific Inc. (NYSE:MLSS) announced the purchase of its CompuFlo Epidural and CathCheck Verification System disposables from two additional leading hospitals. The company added that the new orders will help expand its geographic footprint.
- 12/28/2021
|
Milestone Scientific inks deal with Andau Medical to distribute STA Single Tooth Anesthesia System in the US and Canada
- Milestone Scientific Inc (NYSE:MLSS) has announced an agreement with medical and dental device company Andau Medical to distribute Milestone's STA Single Tooth Anesthesia System in the US and Canada. “We initially began our collaboration with Andau around our CompuFlo Epidural Instrument in Canada,” Milestone Scientific CEO Arjan Haverhals said in a statement.
- 12/23/2021
|
Milestone Scientific, the pressure sensing medtech group, enjoying revenue and cash flow growth
- Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global partners What Milestone Scientific Inc does: Milestone Scientific Inc (NYSEAMERICAN:MLSS) is a medical device research and development (R&D) group. It designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics to know what the pressure at the tip of needle is at any time.
- 12/22/2021
|
Milestone Scientific announces sale of its CompuFlo Epidural and CathCheck Verification System disposables to a Northeast teaching hospital
- Milestone Scientific Inc (NYSE:MLSS) said that following a successful trial, it has signed an agreement for the purchase of its CompuFlo Epidural and CathCheck Verification System disposables with a major Northeast teaching hospital. “We are honored to announce the adoption of our CompuFlo Epidural and CathCheck Verification System by yet another important and prestigious hospital,” said Arjan Haverhals, CEO of Milestone Scientific in a statement.
- 12/22/2021
|
Milestone Scientific says recognized pain management expert Dr Miguel de la Garza has adopted its CompuFlo Epidural instrument
- Milestone Scientific Inc (NYSE:MLSS) has announced that Dr Miguel de la Garza, a recognized expert in pain management, has begun incorporating the company's CompuFlo Epidural instrument into his practice for pain management. The move follows approval by Surgery Partners, one of the largest and growing surgical services businesses in the United States, it added.
- 12/01/2021
|
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q3 2021 Results - Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q3 2021 Results - Earnings Call Transcript
- 11/15/2021
|
Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates
- Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -50.00% and -6.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/15/2021
|
Milestone Scientific, the pressure sensing medtech group, enjoying revenue and cash flow growth
- Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global partners What Milestone Scientific Inc does: Milestone Scientific Inc (NYSEAMERICAN:MLSS) is a medical device research and development (R&D) group. It designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics to know what the pressure at the tip of needle is at any time.
- 11/15/2021
|
Milestone Scientific says dental office reopenings and sales and marketing efforts boosted revenue in third quarter
- Milestone Scientific Inc (NYSE:MLSS) reported a 69% uplift in revenue in its third quarter to end-September compared to last year, as dental offices began opening up again and the group's medical sales and marketing initiatives began to stick. For the three months to September 30, the medtech group said revenue was around $2.1 million versus $1.2 million in the year-ago quarter, with dental revenue increasing around $0.8 million on last year.
- 11/15/2021
|
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
- Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 11/09/2021
|
Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021
- ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida.
- 10/18/2021
|
Milestone Scientific initiates international expansion for its CompuFlo Epidural Instrument
- Milestone Scientific Inc. (NYSE:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, said it has added three new international distributors for the CompuFlo Epidural Instrument, including Andau Medical in Canada, Sanolabor DD in Slovenia, and New Al Farwaniya Surgicals and Medical Equipment LLC in the United Arab Emirates (UAE). “The CompuFlo Epidural Instrument is an important and revolutionary advancement that will significantly improve women's health during one of the most pivotal moments in life, the birth of a child,” Andau Medical CEO Sandi Wright said in a statement.
- 10/14/2021
|
Milestone Scientific Announces International Expansion for their CompuFlo® Epidural Instrument
- Signs distributors in Canada, Slovenia and United Arab Emirates; expands commercial usage at leading hospital in Germany Signs distributors in Canada, Slovenia and United Arab Emirates; expands commercial usage at leading hospital in Germany
- 10/14/2021
|
Milestone Scientific to Present at Microcap Rodeo's Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October 6, 2021
- ROSELAND, NJ / ACCESSWIRE / October 5, 2021 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at the Fall Harvest - Best Ideas from the Buy-Side conference, which is being held virtually on October 5 - 8, 2021. Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will present at the conference.
- 10/05/2021
|
Milestone Scientific approved to supply its CompuFlo Epidural and CathCheck Verification System disposables across Florida's renowned Memorial Healthcare System
- Milestone Scientific Inc told investors that its sales force expansion was paying off, as the company had won approval to supply its CompuFlo Epidural and CathCheck Verification System disposables across Florida's renowned Memorial Healthcare System network of hospitals. The company, which has developed instruments that provide painless and precise injections, also reported that the flagship institution - the Memorial Regional Hospital in Hollywood - had begun using its CompuFlo Epidural Instrument.
- 10/04/2021
|
Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida's Memorial Heathcare System
- ROSELAND, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that Memorial Regional Hospital in Hollywood, Fla., has begun the use of the CompuFlo Epidural Instrument. Memorial Regional Hospital is the flagship facility of the healthcare system and is one of the largest hospitals in Florida. Additionally, Milestone has received approval to eventually supply its CompuFlo Epidural and CathCheck Verification System disposables across Memorial Healthcare System network of hospitals, which also includes Joe DiMaggio Children's Hospital, Memorial Regional Hospital South, Memorial Hospital West, Memorial Hospital Miramar and Memorial Hospital Pembroke.
- 10/04/2021
|
Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q2 2021 Results - Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q2 2021 Results - Earnings Call Transcript
- 08/16/2021
|
Milestone Scientific, Inc. (MLSS) Reports Q2 Loss, Tops Revenue Estimates
- Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -100.00% and 7.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/16/2021
|
Milestone Scientific reports fourteen-fold increase in revenue in 2Q as dental business recovers
- Milestone Scientific Inc revealed that the re-opening of dentists in the US and globally helped the medtech group post a US$2.3 million increase in revenue to US$2.4 million in its second-quarter this year compared to US$168,000 for the year earlier period. Gross profit for the three months to June 30, 2021, came in at US$1.4 million versus US$112,000 for the same quarter in 2020.
- 08/16/2021
|
Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021
- ROSELAND, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2021.
- 08/16/2021
|
Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call
- ROSELAND, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company's financial results for the second quarter ended June 30, 2021, as well as the Company's corporate progress and other developments.
- 08/11/2021
|
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
- Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/06/2021
|
Milestone Scientific expands sales in Texas as UTMB Health Clear Lake Campus Hospital begins using CompuFlo epidural instrument
- Milestone Scientific Inc (NYSE:MLSS) has expanded sales of its equipment in Texas, saying that the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has now begun using its CompuFlo Epidural Instrument. UTMB is a major academic health sciences center of global influence and the move comes after the MedTech group began selling CompuFlo disposables previously to the UTMB Health Galveston Campus Hospital.
- 07/07/2021
|
Implied Volatility Surging for Milestone Scientific (MLSS) Stock Options
- Investors need to pay close attention to Milestone Scientific (MLSS) stock based on the movements in the options market lately.
- 06/28/2021
|
Milestone Scientific expands sales team to capitalize on interest in CompuFlo and CathCheck medical devices
- Milestone Scientific Inc (NYSE:MLSS) is boosting its medical sales team with the appointment of Chet Trechock as vice president of sales medical along with three new representatives. Trechock has over 25 years of experience in the medical sales industry focusing on pain management, neurosurgery, neurology and orthopedics.
- 06/23/2021
|
Milestone Scientific to Participate in the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd
- ROSELAND, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, has been invited to present at the "Summer Solstice – Best Ideas from the Buy-Side" conference, which is being held virtually on June 1st – 4th, 2021.
- 05/27/2021
|
Milestone Scientific, the pressure sensing medtech group, enjoying revenue and cash flow growth
- Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global partners What Milestone Scientific Inc does: Milestone Scientific Inc (NYSEAMERICAN:MLSS) is a medical device research and development (R&D) group. It designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics to know what the pressure at the tip of needle is at any time.
- 05/21/2021
|
Milestone Scientific Inc. (MLSS) Q1 2021 Results - Earnings Call Transcript
- Milestone Scientific Inc. (MLSS) Q1 2021 Results - Earnings Call Transcript
- 05/17/2021
|
Milestone Scientific reports double-digit, year-over-year increase in 1Q revenue
- Milestone Scientific Inc (NYSE:MLSS) reports that first-quarter revenue increased by double-digits year-over-year as the company commercializes its CompuFlo Epidural System. The company also announced that it closed the quarter ended March 31 with about $17 million in cash and cash equivalents -- a substantial runway that will allow Milestone Scientific to accelerate its sales and marketing activities around its dental and medical instruments.
- 05/17/2021
|
Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021
- Achieves 32% sequential increase in revenue for Q1 2021 versus Q4 2020
- 05/17/2021
|
Milestone Scientific promotes its president Arjan Haverhals to the position of CEO
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) has announced the promotion of company president Jan Adriaan (Arjan) Haverhals to be its new chief executive officer (CEO) after Leonard Osser said he intends to step down as the company's interim CEO. Milestone Scientific also said it has appointed Scott Kahn as its new chief financial officer (CFO) effective May 24, succeeding Joseph D'Agostino who retired from the company last month.
- 05/13/2021
|
Milestone Scientific Announces Promotion of Arjan Haverhals to CEO
- Finance veteran Scott Kahn appointed CFO
- 05/13/2021
|
Milestone Scientific Schedules First Quarter 2021 Business Update Conference Call
- ROSELAND, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, May 17, 2021 to discuss the Company's financial results for the first quarter ended March 31, 2021, as well as the Company's corporate progress and other developments.
- 05/12/2021
|
4 Hot Penny Stocks To Watch In May 2021
- Looking for penny stocks to watch in May? Look no further The post 4 Hot Penny Stocks To Watch In May 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 05/04/2021
|
MLSS Stock: From $2.52 To $3.17 (25.79% Increase) Explanation
- The stock price of Milestone Scientific Inc. (NYSEAMERICAN: MLSS) increased from $2.52 to $3.17 (up 25.79%) during intraday trading this morning. This is why it happened.
- 05/03/2021
|
Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
- ROSELAND, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced preliminary financial results for the first quarter of 2021.
- 05/03/2021
|
Milestone Scientific's (MLSS) CEO Leonard Osser on Q4 2020 Results - Earnings Call Transcript
- Milestone Scientific's (MLSS) CEO Leonard Osser on Q4 2020 Results - Earnings Call Transcript
- 04/02/2021
|
Milestone Scientific sees a 78% sequential rise in 4Q revenue powered by its dental business
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) posted fourth-quarter results on Thursday that saw its revenue rocket 78%, compared to the third quarter thanks to its growing dental business and flourishing distribution network. For the period ended December 31, 2020, the Roseland, New Jersey-based developer of computerized drug delivery instruments that provide painless and precise injections, reported a $1 million, or 78% sequential gain in revenue, compared to the third quarter of 2020.
- 04/01/2021
|
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
- Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural System Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural System
- 04/01/2021
|
Milestone Scientific Schedules 2020 Year-End Business Update Conference Call
- ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 4:30 p.m. Eastern Time on Thursday, April 1, 2021 to discuss the Company's financial results for the full year ending December 31, 2020, as well as the Company's corporate progress and other developments.
- 03/30/2021
|
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
- Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 03/22/2021
|
Milestone Scientific to Present at the Q1 Virtual Investor Summit
- ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that Arjan Haverhals, CEO of Wand Dental and President of Milestone Scientific, will be presenting at the Q1 Virtual Investor Summit on March 24th.
- 03/12/2021
|
Milestone Scientific receives notice of allowance for European patent as company seeks to develop device for ultrasound-guided peripheral nerve block procedures
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Wednesday it has received a Notice of Allowance from the European Patent Office as the company seeks to develop a device for ultrasound-guided peripheral nerve block (PNB) procedures. The patent office's decision allows for the company to combine minimum intensity of nerve stimulation (MIS) and real-time injection pressure (IP) monitoring by utilizing Milestone's CompuFlo instrument and associated DPS Dynamic Pressure Sensing Technology to optimize needle tip location in PNB procedures.
- 03/10/2021
|
Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultrasound-Guided PNB Procedures
- ROSELAND, N.J., March 10, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has received Notice of Allowance from the European Patent Office (EPO) combining minimum intensity of nerve stimulation (MIS) and real-time injection pressure (IP) monitoring utilizing Milestone's CompuFlo® instrument and associated DPS Dynamic Pressure Sensing Technology® to optimize needle tip location in ultrasound-guided peripheral nerve block (PNB) procedures. The technology was developed in conjunction with Dr. Olivier Choquet from the Lapeyronie University Hospital Montpellier France, a renowned expert in peripheral nerve block procedures, and Dr. Mark Hochman, D.D.S., Inventor and Clinical Director for Milestone Scientific.
- 03/10/2021
|
Milestone Scientific starts selling CompuFlo/CathCheck disposables to the Medical University of South Carolina
- Milestone Scientific Inc (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, said Tuesday it has begun selling CompuFlo/CathCheck disposables to the Medical University of South Carolina (MUSC). The MUSC University Medical Center is a nationally recognized and leading health sciences university, recently ranked as the number one hospital in South Carolina, the company noted.
- 03/02/2021
|
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina
- ROSELAND, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has begun selling CompuFlo® / CathCheck™ disposables to the Medical University of South Carolina (MUSC). The MUSC University Medical Center is a nationally recognized and leading health sciences university, recently ranked as the number one hospital in South Carolina. MUSC Health owns and operates eight hospitals and provides patient care throughout the state of South Carolina.
- 03/02/2021
|
Milestone Scientific receives Notice of Allowance from US patent office for new CompuPulse system
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Wednesday it had received a Notice of Allowance from the US patent office for its new CompuPulse System. The CompuPulse System integrates Milestone's CompuWave technology with a manual syringe, and the Notice of Allowance relates to a method and apparatus that detects a pulsatile pressure waveform to more easily perform the identification of anatomical target regions.
- 02/24/2021
|
Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patent
- CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placement CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placement
- 02/24/2021
|
Milestone Scientific begins sales of CompuFlo epidural instruments and disposables to University Hospital of Wurzburg
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) said it has begun selling its CompuFloEpidural Instrument and related disposables to the University Hospital of Würzburg (UHW) in Germany. “We appreciate the decision of the University of Wurzburg, in association with Dr Kranke and his team, to purchase our CompuFlo Epidural System.
- 02/23/2021
|
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural Instruments and Disposables to University Hospital of Würzburg in Germany
- ROSELAND, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has begun selling its CompuFlo® Epidural Instrument and related disposables to the University Hospital of Würzburg, one of the leading national hospitals in Germany.
- 02/23/2021
|
Milestone Scientific adds four new North American distributors for its Wand Single Tooth Anesthesia System
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) reported that it has signed three additional distribution agreements in the US and one in Canada for the company's Wand Single Tooth Anesthesia (STA) System. With Monday's announcement, Milestone Scientific noted that it has added eight independent North American distributors in less than one month.
- 02/16/2021
|
Milestone Scientific Adds Three Additional Premier Distributors Providing Robust U.S. Coverage and a New Distributor in Canada for the Company's Dental Instrument
- Brings network to eight independent North American distributors in under one month Brings network to eight independent North American distributors in under one month
- 02/16/2021
|
Milestone Scientific to Participate in the Winter Wonderland Conference- Best Ideas from the Buy-Side
- ROSELAND, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, announced that it will be presenting at the Winter Wonderland Conference, hosted by The MicroCap Rodeo, being held virtually on February 16th - February 19th, 2021.
- 02/12/2021
|
Milestone Scientific, the pressure sensing medtech group, enjoying revenue and cash flow growth
- Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global partners What Milestone Scientific Inc does: Milestone Scientific Inc (NYSEAMERICAN: MLSS) is a medical device research and development (R&D) group. It designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics to know what the pressure at the tip of needle is at any time.
- 02/10/2021
|
Milestone Scientific, the pressure sensing medtech group, enjoying revenue and cash flow growth
- Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global partners What Milestone Scientific Inc does: Milestone Scientific Inc (NYSEAMERICAN: MLSS) is a medical device research and development (R&D) group. It designs and patents innovative injection technology and specializes in dynamic pressure sensing, which allows medics to know what the pressure at the tip of needle is at any time.
- 02/10/2021
|
Milestone Scientific signs distribution deals with Atlanta Dental and Nashville Dental for its Wand Single Tooth Anesthesia System
- Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Tuesday that it has signed two additional distribution agreements with Atlanta Dental and Nashville Dental for its Wand Single Tooth Anesthesia (STA) System. Atlanta Dental and Nashville Dental are leading distributors of dental products in the US, headquartered in Georgia and Tennessee, respectively.
- 02/09/2021
|
Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee
- Adds four independent U.S. distributors in under one month
- 02/09/2021
|
Milestone Scientific: Poised For A Long Uptrend
- MLSS has an exciting technology for computerized drug delivery which should dramatically cut costs and improve patient outcomes. The technology uses sensors to pinpoint the type of tissue into which drugs are optimally injected.
- 02/04/2021
|
Milestone Scientific Inc. Receives Notice of Allowance for U.S Patent Related to CompuFlo® Disposables
- ROSELAND, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent relating to the disposable component of Milestone's CompuFlo® Instrument.
- 01/20/2021
|
Milestone Scientific Inc. Announces It has Begun Implementing Three-Year Strategy to Expand the World-Wide Global Dental Market
- Agreements have been put into place with two distributors covering Florida, New York and New Jersey
- 01/19/2021
|
Milestone Scientific Inc. Raises Revenue Guidance to Over $2 Million for Q4 2020
- ROSELAND, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today raised revenue guidance to over $2 million for the fourth quarter of 2020, a 67% sequential increase over $1.2 million reported for the third quarter of 2020.
- 01/06/2021
|
Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables
- Milestone's FDA approved CompuFlo and CathCheck instruments and disposables provide significant safety and economic benefits Milestone's FDA approved CompuFlo and CathCheck instruments and disposables provide significant safety and economic benefits
- 01/04/2021
|
Milestone Scientific Inc. CEO to Increase Stock Ownership through Option Exercise
- ROSELAND, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today reported that the Company's Interim CEO, Leonard Osser, plans to exercise up to 336,970 options. In connection with the transaction, he plans to sell a portion of his shares to cover the cost of the options and associated taxes. However, the net impact of the transaction will be an increase in Mr. Osser's overall common stock holdings. Mr. Osser has no plans to sell additional shares.
- 12/16/2020
|
Milestone Wins Could Lead To A Breakout
- MLSS's dental business has almost fully recovered from the pandemic lows, with several tailwinds on the horizon. MLSS progressed its medical side of the business significantly in early Q4 with the announcement of an agreement with Premier, a large group purchasing organization.
- 12/01/2020
|
Milestone Scientific Inc. Reports Continued Growth in Dental Sales
- Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020 Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020
- 11/30/2020
|
Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q3 2020 Results - Earnings Call Transcript
- Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q3 2020 Results - Earnings Call Transcript
- 11/17/2020
|
Milestone Scientific Reports Seven-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
- ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine months ending September 30, 2020.
- 11/17/2020
|
Milestone Scientific Schedules Third Quarter 2020 Conference Call
- ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 17, 2020 to discuss the Company's financial results for the third quarter ended September 30, 2020, as well as the Company's corporate progress and other developments.
- 11/03/2020
|
Milestone's CompuFlo Will Deliver (NYSEMKT:MLSS)
- MLSS has been hit hard by COVID-19, but their dental business has shown strong signs of recovery. The future of MLSS is not dental, but becoming the standard of care in labor and delivery.
- 10/08/2020
|
‘You may never see it as good as it is now’: Some wealthy Americans are prepping their finances for a possible Joe Biden presidency — here’s how
- One San Francisco accountant finishes every client conversation with a discussion about what a Biden administration could mean for portfolios.
- 09/16/2020
|
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
- Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynam
- 08/27/2020
|
Milestone Scientific: A Disastrous Last Quarter But A Promising Product Pipeline
- Milestone markets and sells a computer-controlled anaesthetic delivery system to dentistry practices that typically earns revenues ~$10m per annum.
- 08/24/2020
|
What does the STA Travel collapse mean for travellers?
- Millions of travellers booked formative travel experiences with the company over the past few decades.
- 08/22/2020
|
STA Travel goes into administration as pandemic wreaks havoc on tourism industry
- Many customers are still waiting for refunds or have credit vouchers with the company.
- 08/22/2020
|
STA Travel becomes latest casualty of coronavirus crisis
- Package tour firm, which employed around 500 staff in 50 high street branches in the UK, confirms it has ceased trading
- 08/21/2020
|
STA Travel ceases trading due to covid - & 500 staff could lose their jobs
- MAJOR company STA Travel UK has gone out of business, it has been announced. Thousands of customers are expected to begin chasing refunds after the company, which employed around 500 staff in 50 hi…
- 08/21/2020
|
Coronavirus puts travel agency STA Travel UK out of business
- ‘This distressing news will sadly affect the livelihoods of hundreds of employees,’ said Abta, the travel association
- 08/21/2020
|
STA Travel’s parent company has filed for administration
- UK subsidiary is ‘reviewing its position’
- 08/21/2020
|
STA Travel falls into adminstration with 52 UK shops at risk
- THE future of STA Travel is under threat after as its parent company plans to file for administration. The student travel company has become the latest company to fall victim to the Coronavirus dow…
- 08/20/2020
|
STA Travel falls into administration affecting 52 shops in the UK
- Student travel firm STA Travel has filed for insolvency and become the latest coronavirus High Street victim. Parent company, STA Travel Holding AG which is based in Switzerland, said that that an external administrator would be taking control of the company. STA did not elaborate what the immediate future for the company would be, although some operations around the world are understood to be continuing. The company has 52 shops in the UK.
- 08/20/2020
|
Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q2 2020 Results - Earnings Call Transcript
- Milestone Scientific, Inc. (NYSEMKT:MLSS) Q2 2020 Earnings Conference Call August 17, 2020 08:30 ET Company Participants David Waldman - Investor Relations, Crescendo Communications, LLC Leonard Osser - Interim Chief Executive Officer & Director of China Operations Arjan Haverhals - Chief Executive Officer of Wand Dental Inc.
- 08/17/2020
|
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2020
- ROSELAND, NJ / ACCESSWIRE / August 17, 2020 / Milestone Scientific Inc.
- 08/17/2020
|
Milestone Scientific Schedules Second Quarter 2020 Conference Call
- LIVINGSTON, NJ / ACCESSWIRE / August 13, 2020 / Milestone Scientific Inc.
- 08/13/2020
|
Slovenia Seen Emulating Hungary, Poland with Media Reforms | Balkan Insight
- Slovenia’s right-wing prime minister, Janez Jansa, is taking a leaf out of Viktor Orban’s book with changes to the way public service media are funded and run, watchdogs warn.
- 07/22/2020
|
Puma Biotechnology Licensing Partner Specialised Therapeutics Receives Marketing Approval in Malaysia for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
- Puma Biotechnology's licensing partner Specialised Therapeutics Asia received authorization to market NERLYNX in Malaysia.
- 07/16/2020
|
Edited Transcript of MLSS earnings conference call or presentation 18-May-20 12:30pm GMT
- Q1 2020 Milestone Scientific Inc Earnings Call
- 07/14/2020
|
Project Spotlight: Balancer Labs | Crypto Briefing
- Balancer Labs is one of the most talked-about DeFi projects in crypto. It ties up many key components from open finance to create new tools.
- 07/02/2020
|
Milestone Scientific Announces Closing of $14.6 Million Offering of Common Stock and Warrants | | IT Business Net
- ROSELAND, NJ / ACCESSWIRE / June 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,
- 06/30/2020
|
Milestone Scientific Announces Closing of $14.6 Million Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / June 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $2.15. In addition, Milestone Scientific granted to Maxim Group LLC a 45-day option to purchase up to an additional 978,000 shares of common stock and/or warrants to purchase up to 489,000 shares of common stock for the purposes of covering any over-allotments, at the public offering price less discounts and commissions, of which Maxim Group LLC partially exercised its option to purchase 250,000 shares of common stock and warrants to purchase up to 489,000 shares of common stock.
- 06/30/2020
|
Rising DeFi Protocol Balancer Loses $500,000 To Hacker In Pool Exploit (Updated)
- The Decentralized Finance (DeFi) ecosystem has once again come under attack as a decentralized automated market maker exchange suffered losses close to
- 06/29/2020
|
Attacker drains almost half a million from two Balancer pools | Invezz
- Yesterday, June 28th, an unknown attacker stole nearly half a million ($450,000) from two Balancer pools. Both pools supported multiple tokens, but they were centred around deflationary tokens, according to reports. Details about the attack The attack was actually split into two transactions, which took place about 50 minutes from one another. The first one started at 6.03 pm, while the second one took place starting at 6:49 pm. The exploit only affected those pools that contained STONK and STA — deflationary tokens with transfer fees. The attacker made quite a trek, getting a $23 million flash loan of ETH,
- 06/29/2020
|
Milestone Scientific Added to Russell 3000(R) and Russell Microcap(R) Indexes | | IT Business Net
- ROSELAND, NJ / ACCESSWIRE / June 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,
- 06/29/2020
|
Milestone Scientific Added to Russell 3000(R) and Russell Microcap(R) Indexes
- ROSELAND, NJ / ACCESSWIRE / June 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- 06/29/2020
|
Hacker Drains $500K From DeFi Liquidity Provider Balancer - CoinDesk
- Decentralized finance liquidity provider Balancer Pool says it has fallen victim to a sophisticated hack that exploited a loophole and tricked the protocol into releasing $500,000-worth of tokens.
- 06/29/2020
|
Security Flaw in Balancer Pools Leads to Massive $450K Crypto Hack | NewsBTC
- Two pools on Balancer, an automated market maker protocol, lost more than $450,000 to a hacking incident that mainly attacked deflationary tokens.
- 06/29/2020
|
Hacker Drains Over $450,000 from Balancer Pools | Finance Magnates
- Hacker siphoned more than $450,000 in deflationary tokens on Monday from two multi-token pools on Balancer, an automated market maker protocol.
- 06/29/2020
|
Balancer Pool Exploited, Over $500,000 of Funds Lost | Crypto Briefing
- A hacker found a loophole in a Balancer pool via a deflationary token, resulting in the pool being drained of $535,000.
- 06/29/2020
|
DeFi Exploit Results in Loss of $500k ETH From Balancer Pools - BeInCrypto
- Balancer found itself reeling from an attack over the weekend, which purportedly resulted in the loss of half a million dollars in Ethereum.
- 06/29/2020
|
A Hacker Just Drained $500k in Ethereum & Altcoins From a DeFi App | NewsBTC
- Ethereum's budding decentralized finance ecosystem has gone parabolic over recent weeks.
- 06/29/2020
|
One person is shot after gunman opens fire at Bunn-O-Matic warehouse
- One person has been shot after a gunman opened fire at a Bunn-O-Matic warehouse in Springfield, Illinois on Friday.
- 06/26/2020
|
Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants | | IT Business Net
- ROSELAND, NJ / ACCESSWIRE / June 25, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,
- 06/26/2020
|
Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / June 25, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $2.15. The warrants will be immediately exercisable at a price of $2.60 per share of common stock and will expire three years from the date of issuance.
- 06/26/2020
|
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / June 25, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for manufacturing, marketing, sales and distribution of its CompluFlo® Epidural System and development of new products and new product uses, working capital and general corporate purposes. Maxim Group LLC is acting as sole book-running manager for the offering.
- 06/25/2020
|
Saudi Tourism Authority launches Saudi Summer Campaign
- The Saudi Tourism Authority (STA) has unveiled a new campaign, called Saudi Summer, to encourage residents to explore the Kingdom this year, in lieu of a | eTurboNews | Trends | Travel News | Saudi Arabia travel news
- 06/24/2020
|
Milestone Recovery president: Homeless outreach effort shows how ‘defunding’ can work
- Portland’s HOME Team responds to a need that it is better equipped to handle, using money that would otherwise go to the police.
- 06/23/2020
|
Short Interest in Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Declines By 6.3%
- Milestone Scientific Inc. (NYSEAMERICAN:MLSS) saw a large drop in short interest in June. As of June 15th, there was short interest totalling 1,340,000 shares, a drop of 6.3% from the May 31st total of 1,430,000 shares. Based on an average trading volume of 390,700 shares, the days-to-cover ratio is currently 3.4 days. Approximately 3.7% of […]
- 06/22/2020
|
Tourists trickle back to the Adriatic | bne IntelliNews
- Hundreds of thousands of people are now on the move in Central and Southeast Europe as travel restrictions imposed to contain the novel coronavirus are eased.
- 06/21/2020
|
Coronavirus: Saudi Arabia prepares summer vacation campaign with COVID-19 measures
- Saudi Arabia is preparing to launch a summer vacation campaign in line with coronavirus preventative
- 06/20/2020
|
Embattled MedMen Co-Founders Leave Company | Ganjapreneur
- The co-founders of MedMen Enterprises Inc, Andrew Modlin and Adam Bierman, have stepped down from their roles on the company’s… Read More
- 06/19/2020
|
Quality and high condition are the watchwords for Milestone’s June 27 Premier Antique & Modern Firearms Auction
- Featured: Two guns factory-engraved by William Gough, including Colt 1911 .45 ACP-caliber gold-inlaid pistol estimated at $25,000-$35,000
- 06/19/2020
|
Black is Beautiful for these Huntsville breweries
- 'Diversity is always better.'
- 06/12/2020
|
Why is JK Rowling speaking out now on sex and gender debate?
- What are implications of Harry Potter author’s detailed essay expressing views on transgender law reform?
- 06/11/2020
|
Titan Medical Announces US$18.0 Million Registered Direct Offering Priced At-the-Market
- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a...
- 06/08/2020
|
Milestone Scientific to Present at the Virtual Summer Summit on June 9th
- ROSELAND, NJ / ACCESSWIRE / June 3, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will be presenting at the 2020 Virtual Summer Summit being held on June 9th-12th. Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, is scheduled to present on Tuesday, June 9th at 11:30 a.m. Eastern Time. Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications.
- 06/03/2020
|
Milestone Scientific Appoints Senior Industry & Sales Executive Arjan Haverhals as President & CEO of Wand Dental Inc. Subsidiary
- ROSELAND, NJ / ACCESSWIRE / June 2, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has appointed Jan Adriaan (Arjan) Haverhals as Chief Executive Officer of Wand Dental, Inc., a wholly-owned subsidiary of Milestone Scientific, Inc. Mr. Haverhals replaces Gian Domenico Trombetta who will remain a member of Milestone Scientific's Board of Directors. In addition to his responsibilities with Wand Dental, Mr. Haverhals will also be involved in helping drive new sales and marketing initiatives for the CompuFlo® Epidural Instrument.
- 06/02/2020
|
Janez Kocijancic, Slovenia's top sports official, dies at 78
- LJUBLJANA, Slovenia (AP) - Janez Kocijancic, Slovenia's leading sports official for decades, died on Monday. He was 78.The European Olympic Committees, of...
- 06/01/2020
|
Janez Kocijancic, Slovenia's top sports official, dies at 78
- LJUBLJANA, Slovenia (AP) — Janez Kocijančič, Slovenia's leading sports official for decades, died on Monday. He was 78. The European Olympic Committees, of which Kocijančič was the ruling...
- 06/01/2020
|
Rotunda Capital-Backed Trinity3 Technology Announces New CEO Scott Gill
- Trinity3 Technology, a portfolio company of Rotunda Capital Partners and leading provider of student computing solutions, warranty services, and enter
- 06/01/2020
|
Milestone Scientific Interview to Air on Bloomberg International on the RedChip Money Report
- LIVINGSTON, NJ / ACCESSWIRE / May 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- 05/29/2020
|
Milestone Scientific Regains Compliance with New York Stock Exchange Listing Standards
- LIVINGSTON, NJ / ACCESSWIRE / May 22, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today confirms that it regained compliance with the stockholder's equity requirements under the continued listing standards of the NYSE American LLC ("Exchange"). In November 2018, Milestone Scientific received notice from the Exchange that the Company was not then in compliance with the continued listing standards as set forth in Sections 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide. On December 20, 2018, the Company submitted a plan to achieve compliance (the "Plan") by May 20, 2020.
- 05/22/2020
|
Red Chip to Host Investor Webinar and Q&A Session with Milestone Scientific CEO on May 26
- LIVINGSTON, NJ / ACCESSWIRE / May 22, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Red Chip will host an investor webinar and Q&A; session with Leonard Osser, Interim Chief Executive Officer, to discuss the company's recent developments and upcoming milestones. Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.
- 05/22/2020
|
How a greener homes drive could hold the key to over 150,000 post-Covid jobs
- Two major new reports today have highlighted how relatively modest policy reforms and financial innovations could turbocharge UK decarbonisation efforts and provide thousands of construction jobs
- 05/20/2020
|
This Milestone Scientific Inc. (NYSEMKT:MLSS) Analyst Are Way More Bearish Than They Used To Be
- Market forces rained on the parade of Milestone Scientific Inc. (NYSEMKT:MLSS) shareholders today, when the covering...
- 05/20/2020
|
Earnings Update: Milestone Scientific Inc. (NYSEMKT:MLSS) Just Reported And Analysts Are Trimming Their Forecasts
- Milestone Scientific Inc. (NYSEMKT:MLSS) came out with its first-quarter results last week, and we wanted to see how...
- 05/19/2020
|
Milestone Scientific Provides Business Update for the First Quarter of 2020
- Reports positive feedback and growing interest in CathCheck™ LIVINSTON, NJ / ACCESSWIRE / May 18, 2020 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery ...
- 05/18/2020
|
Milestone Scientific Announces Publication of Study Validating Efficacy of CompuFlo(R) CathCheck(TM) System to Confirm and Monitor the Placement of an Epidural Catheter
- Pressure waveform recording through the epidural catheter resulted in 100% sensitivity and specificity, as well as a positive predictive value of 100% LIVINGSTON, NJ / ACCESSWIRE / May 13, 2020 / Milestone ...
- 05/13/2020
|
Milestone Scientific Schedules First Quarter 2020 Conference Call
- LIVINGSTON, NJ / ACCESSWIRE / May 13, 2020 / Milestone Scientific Inc. (NYSE:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced ...
- 05/13/2020
|
Travellers grounded as virus-hit agents do a refund backflip
- STA is refusing to pay refunds. It marks the latest pandemic gripe about travel agencies, although some are pleading for understanding.
- 05/13/2020
|
Milestone Scientific Schedules Conference Call to Discuss Recent Developments Related to its CompuFlo Epidural System
- LIVINGSTON, NJ / ACCESSWIRE / April 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- 04/29/2020
|
Milestone Scientific Surges Again
- Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) c
- 04/28/2020
|
STA cops $14m fine as travel agents struggle with virus backlash
- The travel agency was charging fees despite leading consumers to believe otherwise.
- 04/24/2020
|
Cleaner air and sunny skies drive all-time UK solar power record
- Significant decline in air pollution and cool, sunny weather sees UK solar generate all-time high of 9.69GW on Monday
- 04/22/2020
|
Milestone Scientific Announces Validation and Integration of CathCheck(TM) Feature into the CompuFlo(R) Epidural System
- LIVINGSTON, NJ / ACCESSWIRE / April 21, 2020 / Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has validated and integrated the new CathCheck™ feature into the CompuFlo® Epidural System. Using CathCheck™, physicians and nurses can monitor the placement of a catheter to determine the presence or absence of a pulsatile waveform (heartbeat) providing new information that can be used to determine if the catheter is in place or has become dislodged from the epidural space. This can be performed within seconds by measuring the pulsatile waveform within the epidural space.
- 04/21/2020
|
Milestone Scientific Announces Successful Economic Study Comparing Total Costs of CompuFlo(R) Epidural System Versus Traditional Epidural Loss of Resistance Technique
- CompuFlo® reduced costs an average of $504 per hospital stay Study results presented for the 45th Annual Regional Anesthesiology and Acute Pain Medicine Meeting 2020 Poster presented by leading researcher ...
- 04/17/2020
|
Milestone Scientific Announces Validation and Implementation of Quick Start to the CompuFlo Epidural System
- LIVINGSTON, NJ / ACCESSWIRE / April 15, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has validated the new "Quick Start," which has been implemented into the CompuFlo® Epidural System. The Quick Start feature simplifies and provides an alternative pathway to reduce the procedure preparation time for the CompuFlo® instrument prior to the procedure.
- 04/15/2020
|
NTIA recommends revoking China Telecom’s common carrier status
- The Trump administration is continuing with actions that cut telecom ties with China, including a new filing from the National Telecommunications and Information Administration that recommends that…
- 04/14/2020
|
Milestone Scientific Announces Closing of Above Market $4.7 Million Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / April 14, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that on April 14, 2020 it closed its previously announced underwritten offering of 4,750,000 shares of its common stock and warrants to purchase up to an aggregate of 2,375,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $0.95. In addition, Milestone Scientific granted to Maxim Group LLC a 45-day option to purchase up to an additional 712,500 shares of common stock and/or warrants to purchase up to 356,250 shares of common stock for the purposes of covering any over-allotments, at the public offering price less discounts and commissions, of which Maxim Group LLC partially exercised its option to purchase 200,000 shares of common stock and warrants to purchase up to 335,000 shares of common stock.
- 04/14/2020
|
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / April 9, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 4,750,000 shares of its common stock and warrants to purchase up to an aggregate of 2,375,000 shares of the its common stock. Each share of common stock is being sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $0.95. The warrants will be immediately exercisable at a price of $1.20 per share of common stock and will expire three years from the date of issuance.
- 04/09/2020
|
The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 8) * Keros Therapeutics Inc (NASDAQ: KROS) (went public Wednesday and traded 25.5% higher to $20.08, up from the IPO price of $16)None of the NYSE- or Nasdaq-listed
- 04/09/2020
|
#TBT: Verizon makes an Oath; Spoiling AT&T’s Straight Path buy; Xfinity Mobile launches … this week in 2017
- Editor’s Note: RCR Wireless News goes all in for “Throwback Thursdays,” tapping into our archives to resuscitate the top headlines from the past. Fire up the time machine, put on the sepia-tinted s…
- 04/09/2020
|
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
- ROSELAND, NJ / ACCESSWIRE / April 8, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. Maxim Group LLC is acting as sole book-running manager for the offering. The securities described above are being offered by Milestone Scientific pursuant to a registration statement (File No. 333-231178) previously filed and declared effective by the Securities and Exchange Commission (SEC).
- 04/08/2020
|
The Consensus EPS Estimates For Milestone Scientific Inc. (NYSEMKT:MLSS) Just Fell A Lot
- Today is shaping up negative for Milestone Scientific Inc. (NYSEMKT:MLSS) shareholders, with the covering analyst...
- 04/04/2020
|
Slovenia’s BSH reportedly restarts production despite coronavirus crisis
- Slovenia’s BSH Hisni Aparati, which was one of the first large manufacturers in the country to halt production over the coronavirus (COVID-19) ...
- 04/01/2020
|
Milestone Scientific (MLSS) Gets a Buy Rating from Maxim Group
- Maxim Group analyst Anthony Vendetti maintained a Buy rating on Milestone Scientific (MLSS) today and set a price target of $3.00. The company's shares
- 04/01/2020
|
Milestone Scientific Inc. (NYSEMKT:MLSS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- As you might know, Milestone Scientific Inc. (NYSEMKT:MLSS) last week released its latest full-year, and things did...
- 04/01/2020
|
The Global Biliary Stent Market is expected to grow from USD 312.12 Million in 2018 to USD 441.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.06%
- New York, March 31, 2020 -- Reportlinker.com announces the release of the report "Global Biliary Stent Market - Premium Insight, Competitive News Feed Analysis, Company.
- 03/31/2020
|
The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 30.) * Athersys Inc (NASDAQ: ATHX) (reacted to $7-million capital injection by Japanese partner) * Quidel Corporation (NASDAQ: QDEL)Down In The Dumps (
- 03/31/2020
|
The Best Bluetooth Speakers for 2020 | Digital Trends
- Bluetooth speakers are everywhere these days, but only a few are worth your hard-earned money. Let us help you cut through the clutter: We've picked the best Bluetooth speakers for every occasion and every budget, from tiny portables to party-powering hi-fi systems. Start your search here.
- 03/31/2020
|
Milestone Scientific Provides 2019 Year-End Business Update; Reports Progress on Commercial Rollout of CompuFlo Epidural System
- LIVINGSTON, NJ / ACCESSWIRE / March 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- 03/30/2020
|
Milestone Scientific Schedules 2019 Year-End Earnings Conference Call
- LIVINGSTON, NJ / ACCESSWIRE / March 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- 03/30/2020
|
Coronavirus: With some bus routes eliminated, Solano Transportation Authority expands other services
- Vincent Ma, marketing and legislative program manager at STA, made the announcement in a press release issued Tuesday, when the program went into effect, as a response to stay-at-home orders from G…
- 03/25/2020
|
Battle to get your holiday cash back as travel shuts down
- Marian and John Vessey, face losing vast sums for nothing after being refused a refund for a £381 hotel booking while John and Gillie Coghlan had been due to tour Amsterdam.
- 03/24/2020
|
Milestone Scientific to Present at the Spring Investor Summit on March 25th
- LIVINGSTON, NJ / ACCESSWIRE / March 24, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will be presenting at the 2020 Spring Investor Summit being held on March 25th-26th, featuring over 500 registered executives and investors. Due to the ongoing concerns related to COVID-19, the Spring Investor Summit, which was originally scheduled to take place in New York City, will now be hosted virtually. Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, is scheduled to present on Wednesday, March 25th at 11:20 a.m. Eastern Time.
- 03/24/2020
|
Does Milestone Scientific Inc. (NYSEMKT:MLSS) Have A Volatile Share Price?
- Anyone researching Milestone Scientific Inc. (NYSEMKT:MLSS) might want to consider the historical volatility of the...
- 03/14/2020
|
Two Small Biotechs See Big Stock Purchases by Their Largest Holders
- Both companies are coming off a lackluster 2019, and remain off highs set in June. La Jolla stock and Milestone stock have gained this year as investors buy up shares.
- 01/15/2020
|
WuXi AppTec : STA Pharmaceutical - WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility | MarketScreener
|
WuXi AppTec : STA's Jinshan Facility Passes EMA Inspection | MarketScreener
|
Path Investments plc Sale of Turkish interests - DirectorsTalk
- Christopher Theis, Chief Executive of Path, commented: “We are delighted to have entered into the STA with Server Fatih Alpay. This transaction marks the welcome withdrawal of our oil and gas interests in Turkey. Our attention is now focussed on completing our acquisition of ARC Marlborough Pty. Limited that we announced on 18 January 2019. ...
- 02/01/2019
|
11 sites for layby flights to book now and pay later | Finder
- Book a flight now and pay for it later at these sites that will let you layby flights. Take up to 9 months to pay with select book now pay later plans.
- 10/24/2016
|
STA Travel Promo Codes for June 2020 | Finder
- Verified working STA Travel promo codes for discounts on tours, flights, accommodation and more with extra discounts for teachers and under-26s.
- 07/27/2015
|
